Global Asthma Therapeutics Market to grow at a CAGR of 4.31% to forecast 2020

15/feb/2017 19:13:21 HTF Market Intelligence Consulting Pvt. Ltd. Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

HTF Market Intelligence released a new research report of 110 pages on title 'Global Asthma Therapeutics Market 2016-2020'  with detailed analysis, forecast and strategies. The study covers key regions that includes Americas, APAC, EMEA and important players such as ALK-Abello, Amgen, Array BioPharma etc.

Request a sample report @ https://www.htfmarketreport.com/sample-report/206552-global-asthma-therapeutics-market

Summary
About Asthma Therapeutics
 
Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.
 
Research analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.
 
Covered in this report
The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.
 
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
 
Research analysts report, Global Asthma Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
 
Key vendors
• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• GSK
• Merck
Other prominent vendors
• ALK-Abello
• Amgen
• Array BioPharma
• Asmacure
• Astellas Pharma
• Atopix Therapeutics
• Axikin Pharmaceuticals
• Chiesi Farmaceutici
• Dynavax Technologies Corp.
• Horizon Pharma
• Hovione Scientia
• Invion
• Ivax
• Kissei Pharmaceutical
• Kyowa Hakko Kirin
• MediciNova
• Mitsubishi Tanabe Pharma Corporation
• Mundipharma
• Nycomed
• Oxagen Limited
• Palobiofarma
• Pearl Therapeutics
• Pharmaking
• Pharmaxis
• Pulmagen Therapeutics
• Regeneron Pharmaceuticals
• Revalesio
• RSPR Pharma AB
• SAMA Pharmaceuticals
• Sanofi
• Skyepharma
• SolAeroMed
• Stallergenes
• Sterna Biologicals
• Synairgen
• Theron Pharmaceuticals
• UCB Pharma
• Vectura
• Verona Pharma
• Whanin Pharmaceutical Company

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=206552

Market driver
• Huge market potential for mAbs
• For a full, detailed list, view our report
 
Market challenge
• Increased preference for CAM
• For a full, detailed list, view our report
 
Market trend
• Innovative technologies for drug delivery
• For a full, detailed list, view our report
 
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
 
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/206552-global-asthma-therapeutics-market

PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Breakthrough in asthma research
• Asthma: An overview
PART 05: Pipeline portfolio
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Key buying criteria for asthma drugs
PART 08: Market segmentation by type of treatment
• Preventive medications
• Quick-relief medications
• Others
PART 09: Market segmentation by drug class
• Combination therapies
• Bronchodilators
• Immunosuppressants
• Leukotriene antagonists
• Mast cell stabilizers
PART 10: Segmentation by route of administration
• Inhalation
• Parenteral
• Oral
PART 11: Drug delivery devices market for asthma drugs 
• Market overview
• Market segmentation by product type
PART 12: Geographical segmentation
• Global asthma therapeutics market by geography 2015-2020
• Asthma therapeutics market in Americas
• Asthma therapeutics market in EMEA
• Asthma therapeutics market in APAC
PART 13: Market drivers
• Huge market potential for mAbs
• New product approvals minimizing the impact of generic erosion
• Increasing rate of allergies due to environmental pollution
PART 14: Impact of drivers
PART 15: Market challenges
• Increased preference for CAM
• Poor patient adherence toward controller medications……………. Continued

Read Detailed Table of Content @ https://www.htfmarketreport.com/reports/206552-global-asthma-therapeutics-market

Contact Us:
CRAIG FRANCIS (PR & Marketing Manager)
sales@htfmarketreport.com
Ph: +1 (206) 317 1218

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl